Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

02/02/2022 06:00

Feb 2 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             6.27                6.68             9.10     
                                     (-21.3 pct)                  
  Operating      loss 95 mln        loss 594 mln        60 mln    
  Recurring      loss 57 mln        loss 460 mln        80 mln    
  Net              210 mln          loss 556 mln        290 mln   
  EPS             6.06 yen         loss 16.03 yen      8.36 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T